This is an interesting suggestion, as the "undervalued" metrics are not there - P/E in 40+ range even after their FIM, and projected EPS is dismal. But I agree that it may be a good time to buy the dip for a short term bet.
Printable View
All I know is . . . my pre-election buy of Smith & Wesson (now AOBC) has sucked beyond comprehension. Hopefully they turn that around. What a dog that has become.
JD.com, Alibaba, and Tencent are the Amazons of China. Chinese e-commerce is still a relatively young frontier compared to the US...
You just missed a big opportunity with Editas Medicine... I will keep my position in it for at least a few more years though...it could be the Microsoft of the medical world...